Myriad Genetics, Inc. (MYGN) analyst actions
Rating and price-target actions on MYGN in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the MYGN overview →
9 measured MYGN analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Myriad Genetics, Inc. (MYGN) And Encourages Shareholders to Reach Out | Press release | -0.03% | +0.65% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Myriad Genetics, Inc. (MYGN) And Encourages Stockholders to Reach Out | Press release | -0.15% | — | |
| Myriad Genetics Reports First Quarter 2026 Financial Results; Reiterates 2026 Financial Guidance Reflecting Ongoing Progress in the Cancer Care Continuum Business | Press release | +2.01% | -2.84% | |
| Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution | Press release | -12.93% | -20.47% | |
| Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution | Press release | -2.02% | -12.94% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Myriad Genetics, Inc. (MYGN) And Encourages Shareholders to Reach Out | Press release | +1.52% | +5.06% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Myriad Genetics, Inc. (MYGN) And Encourages Stockholders to Reach Out | Press release | -0.64% | +4.32% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Myriad Genetics, Inc. (MYGN) And Encourages Stockholders to Reach Out | Press release | -1.01% | -1.12% | |
| Myriad Genetics Chief Financial Officer Bryan Riggsbee Retires; Scott Leffler Appointed as Successor; Reiterates Previously Issued Financial Guidance | Press release | +3.09% | +3.70% |
Keep exploring
More MYGN: earnings → · SEC filings → · MYGN overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| VICAL (VICL) | 574 | -0.00% | 38% |
| Becton, Dickinson and Company (BDX) | 573 | -0.01% | 50% |
| Tilray Brands, Inc. (TLRY) | 558 | -0.32% | 41% |
| PERNIX THERAPEUTICS HOLDINGS (PTX) | 557 | -0.19% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.